RESUMEN
In vertebrates, certain Hox genes are known to control cellular identities along the anterior-posterior (A-P) axis in the developing hindbrain. In mouse Hoxa3 mutants, truncation of the glossopharyngeal (IXth) nerve or the fusion of the IXth and vagus (Xth) nerves was reported, although its underlying mechanism is largely unknown. To elucidate the mechanism of the IXth nerve defects, we reexamined the phenotype of Hoxa3 mutant embryos. In Hoxa3 mutants, we observed an abnormal caudal stream of the migrating Hoxa3-expressing neural crest cells at the prospective IXth nerve-forming area. Dorsomedial migration of the placode-derived neuronal precursor cells of the IXth nerve was also affected. Motor neurons at rhombomere 6 (r6), where those of the IXth nerve were positioned, often projected axons to the Xth nerve. In summary, the Hoxa3 gene has crucial roles in ensuring the correct axon projection pattern of all three components of the IXth nerve, i.e., motor neurons and sensory neurons of the proximal and distal ganglia.
Asunto(s)
Desarrollo Embrionario y Fetal/fisiología , Nervio Glosofaríngeo/citología , Proteínas de Homeodominio/fisiología , Animales , Movimiento Celular , Inmunohistoquímica , Ratones , Ratones Mutantes , Neuronas Motoras/citología , Fenotipo , Reacción en Cadena de la PolimerasaRESUMEN
A carcinogenicity study of polyoxyethylene(10)nonylphenyl ether (NP-10) to B6C3F1 mouse was performed using 50 females per group of 4 study groups, or 200 mice in total. Diets containing NP-10 at 0, 500, 1500 and 4500 ppm were prepared and orally administered to the animals repeatedly for 104 weeks, and observation of general conditions, body weight analysis, food consumption analysis, hematologic examination, organ weight analysis and pathological examination were performed. The results are summarized as follows. The mean intake of the test substance in the 500, 1500 and 4500 ppm groups for 104 weeks was 81.5, 254 and 873 mg/kg/day, respectively. There were no differences observed in mortality among the groups and the mortality did not exceed the background data in any groups. There were no signs attributable to the administration of the test substance, and various signs which increased in occurrence with aging were observed in all groups at a similar frequency. Body weight gain was suppressed only in the 4500 ppm group throughout the entire administration period. Food consumption was increased in all treated groups around the early stage of administration and, thereafter, in the 1500 and 4500 ppm groups until the mid-stage of administration. Decreased food efficiency was observed in the 4500 ppm group alone. As a result of the hematologic examination, no changes attributable to the administration of the test substance were observed in any groups. As a result of the organ weight analysis, lower absolute weights of the liver and kidney and higher relative weights of the brain, liver and kidney, which were considered to be changes accompanying the suppressed body weight gain, were observed in the 4500 ppm group. The pathological examination revealed no marked changes in the gross findings in the treated groups. As a result of the histological examination, there were no neoplastic or non-neoplastic lesions in the treated groups which were unequivocally observed to have increased in occurrence. As the above findings show, NP-10 did not cause any increase in the incidence of neoplastic lesions in the mouse by oral administration for 2 years at 873 mg/kg/day (4500 ppm) and was determined to have no carcinogenicity.
Asunto(s)
Neoplasias Experimentales/inducido químicamente , Polietilenglicoles/toxicidad , Tensoactivos/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Pruebas de Carcinogenicidad , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Femenino , RatonesRESUMEN
Chronic toxicity and carcinogenicity of polyoxyethylene(10)nonylphenyl ether (NP-10) to Fischer 344 rats were investigated using 70 females per group in 4 study groups, or 280 rats in total. Diets containing NP-10 at 0, 1000, 3000 and 9000 ppm were prepared and orally administered to the animals repeatedly for 52 weeks for a chronic toxicity study and for 104 weeks for a carcinogenicity study. Observations of general condition, body weight analysis, food consumption analysis, hematologic examination, blood chemistry examination (only at Week 52 of administration), urinalysis (only at Week 52), ophthalmologic examination (immediately prior to administration and at Week 52), organ weight analysis and pathological examination were performed. The results are summarized as follows. The mean intake of the test substance was 60.5, 182 and 559 mg/kg/day in the chronic toxicity study for 52 weeks and 55.2, 166 and 520 mg/kg/day in the carcinogenicity study for 104 weeks in the 1000, 3000 and 9000 ppm groups, respectively. Mortality decreased approximately in a dose-related manner, with 28% in the control group, 26% in the 1000 ppm group, and 14% each in the 3000 and 9000 ppm groups. In general condition, there were no signs attributed to the treatment with NP-10. Body weight gain was suppressed in the 9000 ppm group throughout the administration period and in the 3000 ppm group during Weeks 21-88. Food consumption decreased in the 9000 and 3000 ppm groups. Food efficiency was lower in the 9000 and 3000 ppm groups. As a result of the hematologic examination, hematocrit value, hemoglobin value, red blood cell count, platelet count and MCV were lower and MCH and MCHC higher in the 9000 ppm group at Week 52 of administration. At Week 104, the neutrophil ratio was higher and lymphocyte ratio lower in the 3000 and 9000 ppm groups, and furthermore, hematocrit value, hemoglobin value, MCV and MCH were slightly lower in the 9000 ppm group. In the blood coagulability tests, prothrombin time was slightly shortened in the 9000 ppm group at Week 52. As a result of the blood chemistry examination, total protein and albumin values were higher and total bilirubin, uric acid and trygliceride value lower in the 3000 ppm and higher dose groups. Furthermore, the free cholesterol value was higher and the values of potassium, cholesterol ester ratio, GOT, GPT, ALP and cholinesterase were lower in the 9000 ppm group. As a result of the urinalysis, the specific gravity of urine was higher and urine pH acidic in some animals. As a result of the ophthalmologic examination, no abnormal animals were found in the 9000 ppm group. As a result of the organ weight analysis, absolute and relative weights of the liver and adrenals were higher in the 3000 and/or 9000 ppm groups as changes which were considered attributable to the test substance and, in addition, organs with a lower absolute weight and higher relative weight with the suppressed body weight gain were observed in the 9000 ppm group. The histopathological examination revealed no marked findings in necropsy observation or histology in the treated groups in the animals killed at Weeks 52, 104 as well as those killed moribund and dead animals. In the histological findings, bile duct hyperplasia of liver in the animals killed at Week 52, proliferative duct of pancreas in the animals killed at Week 104, pigment of deposit in pituitary and angiectasis of adrenals in the animals killed at moribund and dead animals were observed in a slightly larger number in the treated groups, but none of these changes were different in degree from the control and were not considered to be specific lesions. As a result of the overall study of the neoplastic lesions of all animals killed on schedule and of moribund and dead animals, no tumors were found in the treated groups which had increased in occurrence. Based on the above findings, it was determined that the no-adverse-effect level in the chronic toxicity study was 1000 ppm (
Asunto(s)
Neoplasias Experimentales/inducido químicamente , Polietilenglicoles/toxicidad , Tensoactivos/toxicidad , Administración Oral , Animales , Proteínas Sanguíneas/análisis , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ingestión de Alimentos/efectos de los fármacos , Femenino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Endogámicas F344RESUMEN
The systemic availability of nicardipine after different routes of administration has been examined in rats, with particular attention to differentiating oral absorption from intestinal and hepatic metabolism. The quantities of nicardipine and its metabolite were determined by capillary column gas chromatography. A linear relationship was shown between the hepatic first-pass effect and dose after hepato-portal administration of nicardipine; the hepatic first-pass effect was calculated to be approximately 80%. However, the availability after oral and rectal administration was found to be more than twice that observed after hepato-portal administration. Partial avoidance of the hepatic first-pass effect after oral and rectal administration are estimated to be 37.3% and 35.2%, respectively, assuming that all absorbed molecules pass through the liver. These findings suggest that the absorption of nicardipine after oral administration also occurs by routes other than the hepato-portal system.
Asunto(s)
Antihipertensivos/metabolismo , Hígado/metabolismo , Nicardipino/metabolismo , Vasodilatadores/metabolismo , Administración Oral , Animales , Antihipertensivos/administración & dosificación , Antihipertensivos/farmacocinética , Área Bajo la Curva , Absorción Intestinal , Masculino , Nicardipino/administración & dosificación , Nicardipino/farmacocinética , Vena Porta , Ratas , Ratas Wistar , Vasodilatadores/administración & dosificación , Vasodilatadores/farmacocinéticaRESUMEN
52-week oral repeated-dose S-1 toxicity studies were conducted. Male and female dogs were orally treated with 0, 0.1, 0.5 or 2.5 mg/kg/day for 52 weeks and permitted to recover for 13 weeks. Furthermore, to estimate the no-toxic dose, male and female dogs were given S-1 orally for 52 weeks at doses of 0, 0.004 and 0.02 mg/kg/day. The 2.5 mg/kg/day regimen produced one dead or moribund dog of each sex; black-brown patch (melanin deposition) and inflammatory changes in the eyes and skin; decreased in body weight gains; increases in MCV, MCH, monocyte ratio, and serum protein and uric acid; decreases in lymphocyte ratio and erythrocyte count, hematocrit, hemoglobin, albumin, A/G ratio, cholesterol (esterified, total and free), phospholipids, triglycerides, cholinesterase activity and creatinine; increases in relative liver and adrenal weights. Histopathological examinations revealed melanin deposits in superficial lymph nodes, increases in macrophage and plasma cell accumulation, and corneal atrophy accompanied by melanin deposits and capillary proliferation. A slight black-brown patch (melanin deposition) in the conjunctiva and skin was observed in the 0.1 and 0.5 mg/kg/day groups. No drug-related changes were observed in groups that received 0.02 and 0.004 mg/kg/day. All changes observed during the treatment period disappeared during recovery except for melanin deposits in the conjunctiva and superficial lymph nodes, corneal opacity, and a few hematological and blood chemistry parameters. In conclusion, the no-toxic dose in these 52-week studies was estimated to be 0.02 mg/kg/day.
Asunto(s)
Antimetabolitos Antineoplásicos/toxicidad , Ácido Oxónico/toxicidad , Piridinas/toxicidad , Tegafur/toxicidad , Administración Oral , Animales , Antimetabolitos Antineoplásicos/administración & dosificación , Análisis Químico de la Sangre , Coagulación Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Perros , Combinación de Medicamentos , Ojo/efectos de los fármacos , Ojo/patología , Oftalmopatías/inducido químicamente , Oftalmopatías/patología , Femenino , Pruebas Hematológicas , Hiperpigmentación/inducido químicamente , Ganglios Linfáticos/efectos de los fármacos , Ganglios Linfáticos/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ácido Oxónico/administración & dosificación , Piridinas/administración & dosificación , Piel/efectos de los fármacos , Piel/patología , Enfermedades de la Piel/inducido químicamente , Tegafur/administración & dosificación , UrinálisisRESUMEN
We ultrastructually examined the chick yolk sac endodermal epithelium and evaluated our findings in combination with the biochemical analysis of serum and yolk lipoproteins. Twenty-five to 30 nm-sized particles were demonstrated to be a principal element of the extracellular yolk mass and these were determined to be yolk very low density lipoprotein (VLDL). The particles were shown to be taken up by the epithelial cells via coated pits and engulfed by plasma membrane invaginations together with yolk subdroplets, another element of the yolk mass. Through apical vacuoles, the two yolk elements were incorporated into yolk drops, which were identified to be one of the lysosomal structures by a cytochemical procedure using acid phosphatase (AcP)ase activity. During the last week of incubation, which is the final third of the incubation period, the digestion seemed to progress rapidly in the yolk drops, which came to resemble lipolysosomes; lipoprotein production became active as expressed by an enlarged Golgi apparatus. The newly produced lipoprotein particles were electron-lucent and irregular in size (50-120 nm). They were sequestered in secretory vacuoles and secreted from the vascular surface of the epithelial cells. Finally, the particles were thought to be taken into the vitelline circulation as plasma lipoproteins. The major component of lipoprotein in serum was determined to be low density lipoprotein (LDL) and high density lipoprotein (HDL), while cholesterol content was found to increase during incubation. We concluded that endodermal epithelial cells participate the synthesis of plasma LDL and HDL. For this synthesis the cells probably apply lipids and apo-protein generated from yolk VLDL degradation.
Asunto(s)
Pollos/metabolismo , Endodermo/citología , Endodermo/fisiología , Lipoproteínas HDL/sangre , Lipoproteínas LDL/sangre , Saco Vitelino/metabolismo , Fosfatasa Ácida/análisis , Animales , Embrión de Pollo , Pollos/sangre , Endodermo/ultraestructura , Células Epiteliales , Epitelio/fisiología , Epitelio/ultraestructura , Aparato de Golgi/ultraestructura , Histocitoquímica , Lipoproteínas HDL/biosíntesis , Lipoproteínas HDL/metabolismo , Lipoproteínas LDL/biosíntesis , Lipoproteínas LDL/metabolismo , Lipoproteínas VLDL/biosíntesis , Lipoproteínas VLDL/sangre , Lipoproteínas VLDL/metabolismo , Microscopía Electrónica , Saco Vitelino/enzimología , Saco Vitelino/ultraestructuraRESUMEN
To enhance the selective delivery of antitumor drugs into regional lymph nodes and cancerous tissues via a hyaluronate (HA) receptor (CD44), we synthesized HA-mitomycin C complex and HA-epirubicin complex. To investigate the specific distribution of HA into regional lymph nodes and to evaluate the HA receptor on lewis lung carcinoma cells, we also synthesized 14C-labelled HA and fluorescent HA (FR-HA). The metabolic studies of 14C-HA and HA-epirubicin complex were performed in rats. The specific distribution of both compounds to the lymph nodes were observed after sc treatment. Internalization mechanisms of HA into carcinoma cells (lewis lung carcinoma) via HA receptor was investigated using fluorescent HA (FR-HA) in vitro. Internalization of FR-HA following binding to the cell surfaces was observed. HA-Mitomycin C (MMC) exhibited potent anti-metastatic effects against lewis lung carcinoma implanted in mice at an extremely low dose (0.01 mg/kg) whereas free MMC had no effects.
Asunto(s)
Antibióticos Antineoplásicos/metabolismo , Epirrubicina/metabolismo , Ácido Hialurónico/metabolismo , Mitomicina/metabolismo , Animales , Antibióticos Antineoplásicos/química , Antibióticos Antineoplásicos/uso terapéutico , Combinación de Medicamentos , Ensayos de Selección de Medicamentos Antitumorales , Epirrubicina/química , Epirrubicina/uso terapéutico , Receptores de Hialuranos/metabolismo , Ácido Hialurónico/química , Ácido Hialurónico/uso terapéutico , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Mitomicina/química , Mitomicina/uso terapéutico , Ratas , Ratas Sprague-Dawley , Distribución Tisular , Células Tumorales CultivadasRESUMEN
Formation and accumulation of lipolysosomes in developing chick hepatocytes were investigated by means of electron microscopy in combination with biochemical analyses of the lipid composition in liver homogenates. The lipolysosomes occurred with highest frequency from days 11 to 14 of incubation. They were usually small and electron-dense, but during development they gradually enlarged with an accompanying reduction in electron density. Coinciding with this enlargement was an accumulation of esterified cholesterol in the liver homogenates. After hatching, an immediate decrease in the size and number of lipolysosomes occurred along with a reduction in the concentration of esterified cholesterol, of which only a very small amount remained by 9 days of age. Instead of cholesterol, triglycerides subsequently increased in concentration and accounted for the major lipid content of the liver homogenates. In keeping with the ultrastructural changes, the total volume of cytoplasmic lipid droplets rapidly increased with increasing age. This transient accumulation of esterified cholesterol within lipolysosomes may be attributed to an excessive uptake and processing of plasma lipoprotein particles, probably derived from the egg yolk. This concept is supported by an abundance of coated pits, endosomes and multivesicular bodies in the embryonic hepatocytes.
Asunto(s)
Embrión de Pollo/anatomía & histología , Pollos/crecimiento & desarrollo , Yema de Huevo/metabolismo , Metabolismo de los Lípidos , Hígado/citología , Lisosomas/fisiología , Animales , Embrión de Pollo/metabolismo , Pollos/anatomía & histología , Pollos/metabolismo , Lipasa/metabolismo , Hígado/embriología , Hígado/crecimiento & desarrollo , Lisosomas/enzimología , Lisosomas/ultraestructura , Microscopía ElectrónicaRESUMEN
In animal models of hemi-Parkinson's disease, survival of grafted nigral cells, their synaptic connections, dopamine (DA) synthesis/release, and recovery from motor disturbances were investigated, and these were compared among 3 groups of animals raised for 3 months, 1 year and 2 years after the transplantation. Fetal nigral DAergic cell suspensions were transplanted in the ipsilateral caudate nucleus of rats with unilateral 6-OHDA lesions in the nigrostriatal DA pathway. Motor disturbances, assessed by methamphetamine-induced rotation, recovered partly in the 2nd week, significantly in the 4th week after the grafting, and remained stable thereafter. Many tyrosine hydroxylase (TH)-positive cells were detected along the grafting tracks. The number of TH-positive cells was similar in the 3 groups of animals. These TH-positive cells made synaptic connections in the host caudate. By in vivo microdialysis measurement, extracellular DA, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) around the grafted sites recovered to 30-100% of those of controls. No significant differences were observed in the concentration of DA, DOPAC and HVA among 3 groups of animals. They also responded to methamphetamine loading though the magnitudes were smaller. Using a TH cDNA probe, TH-positive cells were found to express TH mRNA in in situ hybridization-autoradiographic analysis. Data indicate that grafted fetal DAergic cells survive, synthesize and release DA, make synaptic connections in the host brain and ameliorate motor disturbances for over 2 years. There were no differences in these parameters among the 3 groups of animals, and no untoward side effects were observed even at 2 years after the grafting. Thus it was confirmed that the grafting of neuronal cells into the brain is a promising approach to restore disturbed function.
Asunto(s)
Trasplante de Tejido Encefálico/fisiología , Dopamina/fisiología , Actividad Motora/efectos de los fármacos , Neurotoxinas/toxicidad , Sustancia Negra/trasplante , Animales , Encéfalo/efectos de los fármacos , Encéfalo/patología , Catecolaminas/metabolismo , Núcleo Caudado/efectos de los fármacos , Núcleo Caudado/fisiología , Supervivencia Celular , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/fisiología , Dendritas/ultraestructura , Femenino , Trasplante de Tejido Fetal , Hidroxidopaminas/toxicidad , Metanfetamina/farmacología , Microscopía Electrónica , Oxidopamina , Ratas , Ratas Endogámicas , Sustancia Negra/citología , Sustancia Negra/fisiología , Sinapsis/fisiología , Sinapsis/ultraestructura , Tirosina 3-Monooxigenasa/metabolismoAsunto(s)
Nicardipino/análisis , Animales , Bilis/química , Cromatografía de Gases , Electroquímica , Humanos , Indicadores y Reactivos , Masculino , Nicardipino/sangre , Nicardipino/farmacocinética , Piridinas/análisis , Piridinas/sangre , Piridinas/farmacocinética , Ratas , Estándares de ReferenciaRESUMEN
A general treatment for determination of mean residence time (MRT) and steady-state volume of distribution (Vss) after multiple drug inputs via any mode of administration is presented. For multiple inputs, either simultaneous or consecutive, the mean input time (MIT) can be readily calculated using the general equations presented here. Sample calculations for MIT, MRT, and Vss following different combinations of multiple drug inputs are presented. Errors inherent in noncompartmental area determinations are discussed.
Asunto(s)
Farmacocinética , Modelos Biológicos , Estadística como AsuntoRESUMEN
The difference in disposition of quinidine (Qd) and its diastereomer quinine (Qn) after intravenous administration was examined in rats at doses ranging from 5 to 20 mg/kg. Dose-dependent kinetics in total clearance and in distribution volume of tissue based on a two-compartment model was observed for Qd; there was no evidence of nonlinearity for Qn. However, there was no significant difference between Qd and Qn for blood clearance at doses of 5 and 10 mg/kg, at which the blood clearances were almost equal to hepatic blood flow for both Qd and Qn since the excretion of Qd and Qn into the urine and bile was minimal. This indicates the elimination of these diastereomers to be non-restrictive in the liver. A concentration dependence in unbound volume of tissue distribution and in plasma protein binding was observed for Qd; there was no concentration dependence for Qn. Although affinity of the drug for components on or within the blood cells was not concentration-dependent for either Qd or Qn, a significantly higher binding capacity for Qn than for Qd was observed attributable to blood cell binding. Based on these results, it is suggested that a larger number of binding sites exist for Qn than for Qd in the body. However, the dissociation binding constant for Qd is much lower than for Qn, resulting in a higher binding of Qd and Qn at low concentrations, with a reversal at high concentrations.
Asunto(s)
Quinidina/farmacocinética , Quinina/farmacocinética , Animales , Bilis/metabolismo , Proteínas Sanguíneas/metabolismo , Inyecciones Intravenosas , Masculino , Tasa de Depuración Metabólica , Unión Proteica , Quinidina/administración & dosificación , Quinidina/sangre , Quinina/administración & dosificación , Quinina/sangre , Ratas , Ratas Endogámicas , Estereoisomerismo , Distribución TisularRESUMEN
In a male patient suffering from congenital ectodermal dysplasia with sweating only on the plantar and palmar surface, we found that the anhidrotic eccrine sweat glands became able to produce sweat after repeated local application of acetylcholine. We ultrastructurally examined the sweat glands in skin biopsies before and after acetylcholine treatment. The secretory portion of the sweat glands of the right plantar region was characterized by well-developed basal infoldings and intercellular interdigitations, and also by dilated intercellular spaces and canaliculi. In the flexor region of the right brachium (anhidrotic area), the secretory portion showed hypoplastic features, especially denoted by the presence of few locally distributed basal infoldings and intercellular canaliculi. The secretory cells seemed to be hypofunctional with the nuclei containing much heterochromatin. After treatment, in the flexor region of the left brachium and the right infraclavicular region, where sweating was induced, the secretory portion appeared to be considerably activated, though hypoplastic structures were unchanged: the secretory cell nuclei contained dispersed chromatin, the Golgi apparatus in the dark cells was well developed, and both in the clear cells and the myoepithelial cells micropinocytotic vesicle-like structures increased in number. In ductular cells, mitochondria also increased in number.
Asunto(s)
Acetilcolina/farmacología , Glándulas Ecrinas/ultraestructura , Displasia Ectodérmica/fisiopatología , Glándulas Sudoríparas/ultraestructura , Sudoración/efectos de los fármacos , Acetilcolina/uso terapéutico , Comunicación Celular , Núcleo Celular/ultraestructura , Preescolar , Cromatina/ultraestructura , Glándulas Ecrinas/efectos de los fármacos , Glándulas Ecrinas/metabolismo , Displasia Ectodérmica/tratamiento farmacológico , Humanos , Masculino , Microscopía ElectrónicaRESUMEN
A new type of cell was found in the pancreatic connective tissues of rats following cadmium chloride administration. The cells contained several lipid droplets that were strongly electron-dense after the treatment with oxine, which made cadmium-oxine deposits. This suggested that the lipid droplets stored cadmium or related substances. These cells were named "cadmium-storing cells." Cadmium-storing cells are subdivided into two cell types according to their origins, "fibroblast type" and "pericyte type." The structure and function of the cadmium-storing cell were described and discussed.
Asunto(s)
Cadmio/metabolismo , Páncreas/citología , Animales , Cadmio/farmacocinética , Cloruro de Cadmio , Células del Tejido Conectivo , Masculino , Microscopía Electrónica , Páncreas/metabolismo , Páncreas/ultraestructura , Ratas , Ratas EndogámicasRESUMEN
Based on the concept of physiological pharmacokinetics, the hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit was predicted based on the relationships between principle kinetic parameters and lipophilicity (chloroform-water partition coefficient). Good log-log linear relationships between kinetic parameters and lipophilicity were obtained for the seven barbiturates examined. The values of correlation coefficient were improved slightly by using the corrected values for partition coefficients of nonionic molecules in the cases of principle parameters such as drug-protein and drug-blood cell affinity, intrinsic hepatic clearance, and unbound volume of distribution. There was also a good linear relationship between absorption rate constant (mean absorption time) and lipophilicity. The mean hepatic transit time was negligible for the most lipophilic drug (hexobarbital) examined; this suggests that the mean absorption time for these barbiturates does reflect the absorption process. The available fraction in relation to hepatic first-pass metabolism was well predicted from the lipophilicity by both well-stirred and parallel-tube models, and the difference in the values predicted by both models was minimal. There were good relationships between predicted and observed values for plasma levels after intravenous and oral administration, except for two (cyclobarbital and phenobarbital) of the seven drugs used. The great difference between predicted and observed values for these two drugs was considered due to substituent effects in liver metabolism.
Asunto(s)
Barbitúricos/farmacocinética , Modelos Biológicos , Conejos/metabolismo , Administración Oral , Animales , Barbitúricos/administración & dosificación , Barbitúricos/sangre , Semivida , Inyecciones Intravenosas , Cinética , Matemática , Relación Estructura-ActividadRESUMEN
A sensitive gas chromatographic-electron-capture detection method for the simultaneous determination of the antianginal drug nitroglycerin (GTN) and its dinitrate metabolites (1,2-GDN and 1,3-GDN) was developed. Human plasma samples (1 ml) spiked with 2,6-dinitrotoluene as the internal standard were extracted once with 10 ml of a methylene chloride-pentane mixture (3:7, v/v). Using this solvent system, less contaminants are extracted into the organic phase from plasma, resulting in cleaner chromatograms and prolonged column life. A break point was observed on the standard curves of GTN and GDNs. The two linear regions for the detectable concentrations of GTN are 0.025-0.3 and 0.3-3 ng/ml and for 1,2-GDN and 1,3-GDN they are 0.1-1 and 1-10 ng/ml. The limits of detection by this method for GTN, 1,2-GDN and 1,3-GDN in plasma are 0.025, 0.1 and 0.1 ng/ml, respectively.
Asunto(s)
Nitroglicerina/análogos & derivados , Nitroglicerina/análisis , Animales , Cromatografía de Gases , Perros , Electroquímica , Cromatografía de Gases y Espectrometría de Masas , Humanos , Indicadores y Reactivos , Nitroglicerina/sangre , Nitroglicerina/farmacocinética , SolventesRESUMEN
A major metabolite of carbamazepine (CBZ), CBZ-10, 11-epoxide (EPO), has been reported to possess anticonvulsant properties. Therefore, the present study was undertaken in order to develop a pharmacokinetic model to predict the behavior of EPO in the body after administration of CBZ. The serum concentration-time curves after oral administration of solution of CBZ (200 mg) or EPO (150 mg) in six healthy subjects showed the characteristic "nose", suggesting that disposition of CBZ or EPO could be described by the two-compartment model. The kinetic parameters of disposition for CBZ and EPO were calculated by the method of Wagner, assuming the absolute bioavailabilities of CBZ and EPO to be 1.0 and 0.81, respectively. Total body clearance and elimination rate constant of EPO were very much larger than those of the parent drug but there was no statistically significant difference in the distribution volume between CBZ and EPO. The formation rate of EPO was calculated by a deconvolution method, and obeyed Michaelis-Menten kinetics. Based on these findings, a pharmacokinetic model of the fate of CBZ and EPO in humans was developed and the time courses of CBZ and EPO in serum after oral administration of three tablet preparations and a solution containing 200 mg of CBZ were simultaneously fitted to this model by solving the differential equations by the Runge-Kutta-Gill method. There was good agreement between calculated and observed serum values, suggesting that the present model is appropriate to describe the formation and disposition of EPO from CBZ. The formation rate constant of EPO (Vmax/Km/V1) was approximately one-fifteenth of the elimination rate constant of EPO. This suggested a flip-flop model in which the formation of EPO was rate-limiting in humans. The observation that the serum concentrations of EPO after administration of CBZ were one-tenth to one-twentieth of those of the parent drug was well explained by the flip-flop kinetics of EPO, together with the large differences in total body clearance and elimination rate constant between CBZ and EPO.